MENU
GILD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gilead Sciences (GILD) Ownership - Who owns Gilead Sciences?

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
17000
Web
https://www.gilead.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
181.54B
P/E Ratio
17.84
Total Cash
3.18B
Projected Growth
2.18
Total Debt
26.25B
Revenue
30.46B
Risk (Beta)
0.01
Dividend Yield
0.02
Total Cash/Share
2.56
Total Debt/Equity
71.31
Revenue/Share
24.40 USD as % of share price
View a ticker or compare two or three
GILD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
17000
Web
https://www.gilead.com
Who owns Gilead Sciences? GILD symbol Ownership - Tickeron.com